Login / Signup

The role of mucin cell-free DNA detection as a new marker for the study of acellular pseudomyxoma peritonei of appendicular origin by liquid biopsy.

Damián García-OlmoSusana Olmedillas-LópezDelia Cortés-GuiralPedro VillarejoIrene López RojoHéctor GuadalajaraSoledad García Gómez-HerasMariano García-Arranz
Published in: Therapeutic advances in medical oncology (2020)
The three aPMP patients included in this study shared some common aspects: the absence of tumor cells in mucin, the presence of KRAS mutated cfDNA in mucin, and the absence of this tumor-derived mutation in the bloodstream, providing additional information to the routine pathological examinations and suggesting that mucin cfDNA could potentially play a role in aPMP recurrence and prognosis.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • healthcare
  • peritoneal dialysis
  • patient reported outcomes
  • sensitive detection
  • quantum dots